A national vaccination program to prevent swine flu will begin in three weeks, now that the Food and Drug Administration has approved four vaccines against the disease. Preliminary data indicates that one dose should be enough to provide immunity in an adult—not two, as was initially believed—easing fears that there wouldn’t be enough vaccine to cover the entire at-risk population.
Still, supplies of the vaccine will initially be tight. The U.S. has ordered 195 million doses, but the first production runs are expected to turn out about 45 million doses. Those most at risk from the disease, including children and pregnant women, will get first crack at the vaccine.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
‘Businesses that lose money and are uncompetitive won’t survive’Instant Opinion Opinion, comment and editorials of the day
-
Film reviews: Springsteen: Deliver Me From Nowhere, If I Had Legs I’d Kick You, Frankenstein, and Blue MoonFeature A rock star on the rise turns inward, a stressed mother begins to unravel, and more
-
Podcast reviews: ‘Fela Kuti: Fear No Man,’ ‘David Bowie: Changeling’ and ‘The Adam Friedland Show’feature Fela Kuti’s revolutionary life, David Bowie’s early years, and Adam Friedland reinvents the talk show
